Scarica l'app Stockscreener
3.04
4.17%
0.1217
Dopo l'orario di chiusura:
3.06
0.02
+0.66%
Precedente Chiudi:
$2.9183
Aprire:
$2.9
Volume 24 ore:
7,015
Relative Volume:
0.19
Capitalizzazione di mercato:
$9.76M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-1.4206
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
-7.27%
1M Prestazione:
+13.43%
6M Prestazione:
+17.83%
1 anno Prestazione:
+6.66%
Intervallo 1D:
$2.90
$3.1006
Intervallo di 1 settimana:
$2.83
$3.3371
Portata 52W:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Nome
Cyclerion Therapeutics Inc
Settore
Industria
Telefono
617-621-7722
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Confronta CYCN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
3.04 | 10.03M | 556.00K | -5.28M | -6.23M | -2.14 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-20 | Iniziato | Truist | Buy |
| 2021-09-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Iniziato | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie
Renaissance Technologies LLC Invests $34,000 in Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) - Defense World
Cyclerion partners with Guggenheim for $20M stock sale By Investing.com - Investing.com Nigeria
Cyclerion partners with Guggenheim for $20M stock sale - Investing.com Australia
Cyclerion Therapeutics Enters $20M Sales Agreement - TipRanks
CYCN: Company Stock Sale Proceeds Exclude Firm's Benefit | CYCN Stock News - GuruFocus
Head to Head Survey: NewAmsterdam Pharma (NASDAQ:NAMS) vs. Cyclerion Therapeutics (NASDAQ:CYCN) - Defense World
Dementia Market Expected to Experience Major Growth by 2032, According to DelveInsight | Charsire Biotech Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP - Barchart
Top Gainers Today: Reborn Coffee (REBN) Leads with a 65% Surge, Cyclerion (CYCN) and Signing Day Sports (SGN) Follow – market - HPBL
3 US Penny Stocks With Market Caps Over $10M To Consider - Simply Wall St
Cyclerion Therapeutics Inc (NASDAQ: CYCN) Is The Number One Stock Currently Moving. - Stocks Register
Market Recap Check: Cyclerion Therapeutics Inc (CYCN)’s Negative Finish at 4.19, Up/Down -21.24 - The Dwinnex
Small Cap Stocks To ConsiderFebruary 02nd - MarketBeat
Cyclerion Therapeutics announces mixed shelf offering - MSN
Cyclerion Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
Check out these key findings about Cyclerion Therapeutics Inc (CYCN) - SETE News
3 Penny Stocks to Watch Now, 2/4/25 - TipRanks
A company insider recently sold 357,880 shares of Cyclerion Therapeutics Inc [CYCN]. Should You also Consider to Sale? – Knox Daily - Knox Daily
Analyzing CYCN’s current quarter earnings projections - US Post News
Biotech Alert: Searches spiking for these stocks today - TipRanks
Cyclerion’s Stock Surge: A Buying Opportunity? - timothysykes.com
Stock summary: Cyclerion Therapeutics surged by 41.01% over the past five days - Business Upturn
Stock market today: Signing Day Sports +62.89%, Cyclerion Therapeutics +57.43% among top gainers in early trading - Business Upturn
Top Premarket Gainers -January 31, 2025 at 07:32 am EST - Marketscreener.com
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.54%
7.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):